Although Excretion‐EVs did not directly induce drug resistance in recipient bladder cancer cells, their selective enrichment in regulatory proteins, such as H3.2 (H3C14), LAMB1 and CD147, suggests an indirect role in maintaining chemoresistance. Here, H3C14 is linked to urinary bladder carcinoma.